: It is uncertain if anti-retrovirals fully restore immune competence in HIV+ patients. Immunotherapy has been proposed as a way to achieve this goal. IL-2 and IL-12 are cytokines being used or evaluated for this purpose. However, the ability of these cytokines to restore cell mediated immunity (CMI) in HIV+ patients remains unsettled. Thus, there is a need to explore additional approaches to further improve immune reconstitution in HIV+ patients. CD40-CD40 ligand (CD40L) is crucial for T cell-antigen presenting cell (APC) interaction. It promotes IL-12/IFN-gamma secretion, induces APC activation and regulates CD8+ T cell differentiation. Absence of functional CD40L causes immunodeficiency in humans characterized by increased susceptibility to infections with opportunistic pathogens. CD40L is relevant to HIV infection. CD40L induction is defective on CD4+ T cells from HIV+ patients. Exogenous CD40L has profound effects on CMI against HIV and opportunistic pathogens in HIV+ patients. CD40L protects CD4+ T cells from HIV infection and can inhibit HIV replication in dendritic cells. CD40L inhibits growth of opportunistic pathogens in macrophages. Thus, enhancement of CD40L signaling is an attractive candidate for immunotherapy in HIV+ patients.
In Specific Aim 1, we will identify the mechanisms by which CD40L impairs replication of opportunistic pathogens in human macrophages. We will determine if CD40L also stimulates anti-microbial activity of macrophages from HIV+ patients. We will investigate if T cells from HIV+ patients are defective in their capacity to stimulate macrophage anti-microbial activity and if this activity can be enhanced by CD40L. Finally, we will examine if CD40L enhances the capacity of CD8+ T cells to inhibit HIV replication.
In Specific Aim 2, we will ascertain if in vivo administration of exogenous CD40L to T cell-deficient mice increases resistance to an opportunistic pathogen. The mechanisms that mediate this effect will be elucidated. This work will provide crucial information for the evaluation of modulation of CD40L signaling as an approach to immunotherapy in HIV+ individuals.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI048406-02
Application #
6511503
Study Section
Special Emphasis Panel (ZRG1-AARR-4 (01))
Program Officer
Near, Karen A
Project Start
2001-09-20
Project End
2005-05-31
Budget Start
2002-07-01
Budget End
2003-05-31
Support Year
2
Fiscal Year
2002
Total Cost
$254,363
Indirect Cost
Name
University of Cincinnati
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Van Grol, Jennifer; Subauste, Cecilia; Andrade, Rosa M et al. (2010) HIV-1 inhibits autophagy in bystander macrophage/monocytic cells through Src-Akt and STAT3. PLoS One 5:e11733
Portillo, Jose-Andres C; Okenka, Genevieve; Reed, Erin et al. (2010) The CD40-autophagy pathway is needed for host protection despite IFN-?-dependent immunity and CD40 induces autophagy via control of P21 levels. PLoS One 5:e14472
Subauste, Carlos S (2009) Autophagy as an antimicrobial strategy. Expert Rev Anti Infect Ther 7:743-52
Subauste, Carlos S (2009) CD40 and the immune response to parasitic infections. Semin Immunol 21:273-82
Subauste, Carlos S; Andrade, Rosa M; Wessendarp, Matthew (2007) CD40-TRAF6 and autophagy-dependent anti-microbial activity in macrophages. Autophagy 3:245-8
Subauste, Carlos S; Subauste, Angela; Wessendarp, Matthew (2007) Role of CD40-dependent down-regulation of CD154 in impaired induction of CD154 in CD4(+) T cells from HIV-1-infected patients. J Immunol 178:1645-53
Subauste, C S (2006) Primary immunodeficiencies and susceptibility to parasitic infections. Parasite Immunol 28:567-75
Andrade, Rosa M; Wessendarp, Matthew; Gubbels, Marc-Jan et al. (2006) CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes. J Clin Invest 116:2366-77
Andrade, Rosa M; Portillo, Jose-Andres C; Wessendarp, Matthew et al. (2005) CD40 signaling in macrophages induces activity against an intracellular pathogen independently of gamma interferon and reactive nitrogen intermediates. Infect Immun 73:3115-23
Andrade, Rosa M; Wessendarp, Matthew; Portillo, Jose-Andres C et al. (2005) TNF receptor-associated factor 6-dependent CD40 signaling primes macrophages to acquire antimicrobial activity in response to TNF-alpha. J Immunol 175:6014-21

Showing the most recent 10 out of 12 publications